PMELT

New Frontiers in Protein-based Nanomaterials

Coordinatore	UNIVERSITY OF BRISTOL    more Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	2˙168˙862 €
EC contributo	2˙168˙862 €
Programma	FP7-IDEAS-ERC Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	ERC-2010-AdG_20100224
Funding Scheme	ERC-AG
Anno di inizio	2011
Periodo (anno-mese-giorno)	2011-03-01   -   2016-02-29

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	UNIVERSITY OF BRISTOL  Organization address address: TYNDALL AVENUE SENATE HOUSE city: BRISTOL postcode: BS8 1TH contact info Titolo: Ms. Nome: Maria Cognome: Davies Email: send email Telefono: +44 117 331 7352 Fax: +44 117 925 0900	UK (BRISTOL)	hostInstitution	2˙168˙862.00
2	UNIVERSITY OF BRISTOL  Organization address address: TYNDALL AVENUE SENATE HOUSE city: BRISTOL postcode: BS8 1TH contact info Titolo: Prof. Nome: Stephen Cognome: Mann Email: send email Telefono: +44 117 9289935 Fax: +44 117 9290509	UK (BRISTOL)	hostInstitution	2˙168˙862.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'We propose to undertake an ambitious 5 year interdisciplinary programme that introduces a fundamentally new paradigm in protein-based nanomaterials research. The new approach involves two main project themes based respectively on fundamental studies on the structure, function and properties of molten protein polymer surfactant nanoconstructs, and the development of these novel nanomaterials as smart fluids, biotechnological devices and health care products. This proposal represents a new and adventurous area of work for the PI, and will allow unprecedented access to a novel class of nanomaterials with controllable architectures, unique physical properties and inherent biological functionality. In so doing, the work will open up promising new avenues of bionanomaterials research and offer significant advantages over current methods for producing protein-based nanomaterials at extremely high concentration and dosage. In general we expect the research programme to pioneer new frontiers in fundamental research and generate significant economic and societal impact as nanomaterials become increasingly integrated into medical and technological products, and new commercial markets based on nanoscience are discovered.'